Health

U.S. Signs Agreement with Pfizer to Produce COVID-19 Vaccine Doses

The US Department of Health and Human Services and Department of Defense have reached a $1.95 billion agreement with the Pfizer drug company to produce at least 100 million doses of a Covid-19 vaccine, according to HHS Secretary Alex Azar, who made the announcement Wednesday.
The doses, which could start shipping out by the end of this year, will be dispersed depending on availability, will be paid for by the Trump administration at nearly $2 billion.
With the U.S. possibly buying another 500 million doses under the agreement, Azar said that of course the doses “have to be safe and effective” and approved by the Food and Drug Administration.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker